Non-Opioid Pain Treatment Global Market Report 2025

Published Sep 30, 2025

Length 250 Pages

SKU # BRC20428595

Description

Non-Opioid Pain Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-opioid pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for non-opioid pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-opioid pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Medical Cannabis; Menthol-Containing; Omega 3 Fatty Acid-Containing; Botulinum Toxins; Capsaicin-Derived; Other Products

2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids); Acetaminophen; Local Anesthetics; Antidepressants; Anticonvulsants; Corticosteroids; Other Drug Classes

3) By Route Of Administration: Oral; Topical; Injectable; Other Route Of Administrations

4) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Drug Stores; Mail Order Pharmacies

5) By Application: Orthopedic And Musculoskeletal Pain; Postoperative Pain; Cancer Pain; Neuropathic Pain; Other Applications

Subsegments:

1) By Medical Cannabis: Cannabidiol Based Products; Tetrahydrocannabinol Based Products; Combined Cannabinoid Products

2) By Menthol Containing: Topical Creams; Gels; Sprays

3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements; Algae Derived Supplements; Krill Oil Derived Supplements

4) By Botulinum Toxins: Onabotulinumtoxin A; Abobotulinumtoxin A; Incobotulinumtoxin A

5) By Capsaicin Derived: Low Concentration Creams; High Concentration Patches; Nasal Sprays

6) By Other Products: Magnesium Based Products; Acupuncture Devices; Transcutaneous Electrical Nerve Stimulation Devices

Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc; Novartis AG; GSK plc; Amgen Inc.; Teva Pharmaceutical Industries Limited; Vertex Pharmaceuticals Incorporated; SUN PHARMACEUTICAL INDUSTRIES LIMITED; Perrigo Company Public Limited Company; Dr. Reddy's Laboratories; HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY; Pacira BioSciences Inc; Heron Therapeutics Inc; AFT Pharmaceuticals Limited; Vivozon Pharmaceutical Co. Ltd; Levicept Ltd; Algiax Pharmaceuticals GmbH; Latigo Biotherapeutics Inc; Hyloris Pharmaceuticals SA

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Non-Opioid Pain Treatment Market Characteristics
3. Non-Opioid Pain Treatment Market Trends And Strategies
4. Non-Opioid Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market: 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Non-Opioid Pain Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Non-Opioid Pain Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Non-Opioid Pain Treatment Market Growth Rate Analysis; 5.4. Global Non-Opioid Pain Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Non-Opioid Pain Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Non-Opioid Pain Treatment Total Addressable Market (TAM)
6. Non-Opioid Pain Treatment Market Segmentation: 6.1. Global Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Medical Cannabis; Menthol-Containing; Omega 3 Fatty Acid-Containing; Botulinum Toxins; Capsaicin-Derived; Other Products; 6.2. Global Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Nonsteroidal Anti-Inflammatory Drugs (Nsaids); Acetaminophen; Local Anesthetics; Antidepressants; Anticonvulsants; Corticosteroids; Other Drug Classes; 6.3. Global Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Oral; Topical; Injectable; Other Route Of Administrations; 6.4. Global Non-Opioid Pain Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospitals Pharmacies; Retail Pharmacies; Drug Stores; Mail Order Pharmacies; 6.5. Global Non-Opioid Pain Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Orthopaedic And Musculoskeletal Pain; Postoperative Pain; Cancer Pain; Neuropathic Pain; Other Applications; 6.6. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Medical Cannabis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Cannabidiol Based Products; Tetrahydrocannabinol Based Products; Combined Cannabinoid Products; 6.7. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Menthol Containing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Topical Creams; Gels; Sprays; 6.8. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Omega 3 Fatty Acid Containing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Fish Oil Derived Supplements; Algae Derived Supplements; Krill Oil Derived Supplements; 6.9. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Botulinum Toxins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; OnabotulinumtoxinA; AbobotulinumtoxinA; IncobotulinumtoxinA; 6.10. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Capsaicin Derived, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Low Concentration Creams; High Concentration Patches; Nasal Sprays; 6.11. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Magnesium Based Products; Acupuncture Devices; Transcutaneous Electrical Nerve Stimulation Devices
7. Non-Opioid Pain Treatment Market Regional And Country Analysis: 7.1. Global Non-Opioid Pain Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Non-Opioid Pain Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Non-Opioid Pain Treatment Market: 8.1. Asia-Pacific Non-Opioid Pain Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Non-Opioid Pain Treatment Market: 9.1. China Non-Opioid Pain Treatment Market Overview; 9.2. China Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Non-Opioid Pain Treatment Market: 10.1. India Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Non-Opioid Pain Treatment Market: 11.1. Japan Non-Opioid Pain Treatment Market Overview; 11.2. Japan Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Non-Opioid Pain Treatment Market: 12.1. Australia Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Non-Opioid Pain Treatment Market: 13.1. Indonesia Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Non-Opioid Pain Treatment Market: 14.1. South Korea Non-Opioid Pain Treatment Market Overview; 14.2. South Korea Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Non-Opioid Pain Treatment Market: 15.1. Western Europe Non-Opioid Pain Treatment Market Overview; 15.2. Western Europe Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Non-Opioid Pain Treatment Market: 16.1. UK Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Non-Opioid Pain Treatment Market: 17.1. Germany Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Non-Opioid Pain Treatment Market: 18.1. France Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Non-Opioid Pain Treatment Market: 19.1. Italy Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Non-Opioid Pain Treatment Market: 20.1. Spain Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Non-Opioid Pain Treatment Market: 21.1. Eastern Europe Non-Opioid Pain Treatment Market Overview; 21.2. Eastern Europe Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Non-Opioid Pain Treatment Market: 22.1. Russia Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Non-Opioid Pain Treatment Market: 23.1. North America Non-Opioid Pain Treatment Market Overview; 23.2. North America Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Non-Opioid Pain Treatment Market: 24.1. USA Non-Opioid Pain Treatment Market Overview; 24.2. USA Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Non-Opioid Pain Treatment Market: 25.1. Canada Non-Opioid Pain Treatment Market Overview; 25.2. Canada Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Non-Opioid Pain Treatment Market: 26.1. South America Non-Opioid Pain Treatment Market Overview; 26.2. South America Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Non-Opioid Pain Treatment Market: 27.1. Brazil Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Non-Opioid Pain Treatment Market: 28.1. Middle East Non-Opioid Pain Treatment Market Overview; 28.2. Middle East Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Non-Opioid Pain Treatment Market: 29.1. Africa Non-Opioid Pain Treatment Market Overview; 29.2. Africa Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Non-Opioid Pain Treatment Market Competitive Landscape And Company Profiles: 30.1. Non-Opioid Pain Treatment Market Competitive Landscape; 30.2. Non-Opioid Pain Treatment Market Company Profiles; 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis
31. Non-Opioid Pain Treatment Market Other Major And Innovative Companies: 31.1. Amgen Inc.; 31.2. Teva Pharmaceutical Industries Limited; 31.3. Vertex Pharmaceuticals Incorporated; 31.4. SUN PHARMACEUTICAL INDUSTRIES LIMITED; 31.5. Perrigo Company Public Limited Company; 31.6. Dr. Reddy's Laboratories; 31.7. HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY; 31.8. Pacira BioSciences Inc; 31.9. Heron Therapeutics Inc; 31.10. AFT Pharmaceuticals Limited; 31.11. Vivozon Pharmaceutical Co. Ltd; 31.12. Levicept Ltd; 31.13. Algiax Pharmaceuticals GmbH; 31.14. Latigo Biotherapeutics Inc; 31.15. Hyloris Pharmaceuticals SA
32. Global Non-Opioid Pain Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Non-Opioid Pain Treatment Market
34. Recent Developments In The Non-Opioid Pain Treatment Market
35. Non-Opioid Pain Treatment Market High Potential Countries, Segments and Strategies: 35.1 Non-Opioid Pain Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Non-Opioid Pain Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Non-Opioid Pain Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now